My Baby Biome is an observational study that will use 600 infant stool samples to determine the biomarkers associated with a healthy infant gut. Biomarkers identified in this study will be used to develop precision probiotics and LBPs for improving infant gut health outcomes to the benefit of all infants. Parents will be asked to submit follow-up questionnaires regarding infant immune health to improve insights obtained from the data.
Study Type
OBSERVATIONAL
Enrollment
430
Persephone Biosciences, Inc.
San Diego, California, United States
Determine the composition of a healthy infant microbiome
Stool samples will be analyzed for bacterial metagenomics, metabolomics, proteomics, and transcriptomics to define biomarkers (such as bacteria or proteins) that are correlated with healthy infants as defined by the accompanying questionnaire.
Time frame: 6-12 Months
Evaluate impact of the microbiome on immune adverse events
Metadata from questionnaires regarding child immune health will be correlated with the metagenomic gut microbiome composition obtained from the stool sample to define the impact of individual strains on immune adverse events (i.e. allergies, diabetes, asthma, eczema)
Time frame: 7 Years
Build a library of samples and data for future research
Samples will be stored and data saved in a HIPAA-compliant database. Samples will be linked to patient metadata.
Time frame: 6-12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.